University of Minnesota Medical Center Fairview: M Health Fairview University of Minnesota Medical Center, Minneapolis, USA.
CTSI: University of Minnesota Twin Cities Clinical and Translational Science Institute, Minneapolis, USA.
Pediatr Nephrol. 2024 Oct;39(10):3095-3102. doi: 10.1007/s00467-024-06412-7. Epub 2024 Jun 1.
Heart transplant recipients frequently require kidney transplantation for concomitant advanced chronic kidney disease. Data on simultaneous (heart and kidney transplants performed simultaneously) versus sequential (heart transplant performed before kidney) heart-kidney transplants in children are limited. Herein, we compare kidney transplant outcomes between the two groups.
We used the Scientific Registry of Transplant Recipients to identify all pediatric (age <21 years) heart transplant recipients who also received a kidney transplant within 10 years of the heart transplant. We divided the study cohort into simultaneous heart-kidney and sequential heart-kidney recipients. We compared patient and death-censored graft survival using the Cox regression, adjusting for age at kidney transplant, sex, race, pre-transplant dialysis, donor type, and prior kidney transplant. We evaluated delayed graft function (defined as dialysis within the first week posttransplant) using logistic regression.
Our analysis cohort included 165 recipients (86 simultaneous and 79 sequential). The incidence of delayed graft function was higher in simultaneous recipients (22.4 vs. 7.7%, p=0.017), but the difference lost statistical significance on multivariable analysis. We found no difference in patient survival (aHR 0.97; 95% CI 0.39, 2.41; p=0.95) after kidney transplant but higher death-censored kidney graft survival in sequential heart-kidney recipients compared with simultaneous heart-kidney recipients (aHR 4.26; 95% CI 1.21, 14.9; p=0.02).
Sequential heart-kidney transplants are associated with higher death-censored kidney allograft survival in children compared with simultaneous heart-kidney transplants.
由于并发的晚期慢性肾脏病,心脏移植受者常需进行肾移植。关于儿童中同时(心脏和肾同时移植)与序贯(心脏移植先于肾移植)心脏-肾移植的数据有限。在此,我们比较了两组的肾移植结局。
我们使用移植受者科学注册处(Scientific Registry of Transplant Recipients)确定所有年龄<21 岁的儿童心脏移植受者,这些受者在心脏移植后 10 年内还接受了肾移植。我们将研究队列分为同时心脏-肾和序贯心脏-肾受者。我们使用 Cox 回归比较了患者和死亡风险调整移植物存活率,调整因素包括肾移植时的年龄、性别、种族、移植前透析、供体类型和先前的肾移植。我们使用逻辑回归评估了延迟移植物功能(定义为移植后第一周内透析)。
我们的分析队列包括 165 名受者(86 名同时和 79 名序贯)。同时受者的延迟移植物功能发生率较高(22.4% vs. 7.7%,p=0.017),但多变量分析失去了统计学意义。我们发现肾移植后患者生存率无差异(aHR 0.97;95%CI 0.39, 2.41;p=0.95),但与同时心脏-肾移植受者相比,序贯心脏-肾移植受者的死亡风险调整肾移植物存活率更高(aHR 4.26;95%CI 1.21, 14.9;p=0.02)。
与同时心脏-肾移植相比,儿童序贯心脏-肾移植与死亡风险调整的肾移植存活率更高。